Evidence map›Paper›PMID 24347342›Full record

ReviewJournal of cellular physiology2014

Prohibitins role in cellular survival through Ras-Raf-MEK-ERK pathway.

Indrajit Chowdhury, Winston E Thompson, Kelwyn Thomas

Open access · greenAbstract readReview
In one paragraph

Review in Journal of cellular physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 92 citations in OpenAlex.

  1. Article
  2. Review
  3. Targeted Nano-Based Systems for the Anti-Obesity Agent's Delivery.Advances in experimental medicine and biology · 2024
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Frontiers in cellular and infection microbiology · 2022
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. The Ethyl Acetate Extract FromFrontiers in pharmacology · 2021
    Article
  17. PHB2 promotes tumorigenesisTheranostics · 2021
    Article
  18. Article
  19. Prohibitin 1 in liver injury and cancer.Experimental biology and medicine (Maywood, N.J.) · 2020
    Review
  20. Cellular receptors for enterovirus A71.Journal of biomedical science · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Indrajit ChowdhuryDepartment of Obstetrics and Gynecology, Morehouse School of Medicine, Atlanta, Georgia; Reproductive Science Research Program, Morehouse School of Medicine, Atlanta, Georgia.
Winston E Thompson
Kelwyn Thomas
Morehouse School of Medicine · US

Funding

Morehouse School of Medicine Center of Excellence Research Endowment ProgramS21MD000101 · NIMHD · MOREHOUSE SCHOOL OF MEDICINE · PI MONTGOMERY-RICE, VALERIE C. · 2001 to 2015
$74.3M
TRANSCRIPTION FACTORS AND PROSTATE CANCERG12RR003034 · NCRR · MOREHOUSE SCHOOL OF MEDICINE · PI POWELL, MICHAEL D · 1986 to 2011
$32.4M
SP REGULATION OF GENE EXPRESSION IN SPERMATOGENESISU54HD041749 · NICHD · MOREHOUSE SCHOOL OF MEDICINE · PI MANN, DAVID R · 2001 to 2007
$7.4M
Mechanism of Action of Prohibitin in Ovarian Cell FunctionR01HD057235 · NICHD · MOREHOUSE SCHOOL OF MEDICINE · PI THOMPSON, WINSTON E · 2009 to 2014
$1.4M
RENOV OF MEDICAL SCI &EDUCATION BLDGS: RETINAL CELLSC06RR018386 · NCRR · MOREHOUSE SCHOOL OF MEDICINE · PI SULLIVAN, LOUIS W. · 2002 to 2002
$1.3M
NCRR NIH HHS C06 RR018386NCRR NIH HHS C06RR18386NCRR NIH HHS G12 RR003034NCRR NIH HHS G12-RR03034NICHD NIH HHS 1R01HD057235NICHD NIH HHS HD41749NICHD NIH HHS R01 HD057235NICHD NIH HHS U54 HD041749NIMHD NIH HHS S21 MD000101
6 · The paper itself

Abstract

Prohibitins are members of a highly conserved protein family containing the stomatin/prohibitin/flotillin/HflK/C (SPFH) domain (also known as the prohibitin [PHB] domain) found in unicellular eukaryotes, fungi, plants, animals, and humans. Two highly homologous members of prohibitins expressed in eukaryotes are prohibitin (PHB; B-cell receptor associated protein-32, BAP-32) and prohibitin 2/repressor of estrogen receptor activity (PHB2, REA, BAP-37). Both PHB and REA/PHB2 are ubiquitously expressed and are present in multiple cellular compartments including the mitochondria, nucleus, and the plasma membrane. Multiple functions have been attributed to the mitochondrial and nuclear PHB and PHB2/REA including cellular differentiation, anti-proliferation, and morphogenesis. One of the major functions of the prohibitins are in maintaining the functional integrity of the mitochondria and protecting cells from various stresses. In the present review, we focus on the recent research developments indicating that PHB and PHB2/REA are involved in maintaining cellular survival through the Ras-Raf-MEK-Erk pathway. Understanding the molecular mechanisms by which the intracellular signaling pathways utilize prohibitins in governing cellular survival is likely to result in development of therapeutic strategies to overcome various human pathological disorders such as diabetes, obesity, neurological diseases, inflammatory bowel disease, and cancer.

Indexed as

AnimalsCell SurvivalHumansProhibitinsRepressor ProteinsSignal TransductionPHB2 protein, humanPHB protein, humanProhibitinsRepressor Proteins

Identifiers

PMID24347342
PMCPMC4413917
OpenAlexW2102040951

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.